Latest Australian Manufacturing News

Page 2 of 6
OncoSil Medical has gained Saudi FDA approval for its OncoSil™ device, enabling full reimbursement and commercial access in Saudi Arabia, the Middle East's largest healthcare market.
Ada Torres
Ada Torres
20 July 2026
OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.
Ada Torres
Ada Torres
13 July 2026
AdAlta has met a key US$1 million milestone payment under its China collaboration, gaining critical clinical data and securing proprietary materials for Australian manufacturing of its lead CAR-T therapy BZDS1901.
Ada Torres
Ada Torres
1 July 2026
SDI Limited’s acquisition by Beijing Guoci subsidiary is now effective following New South Wales Supreme Court approval, with the ASX suspension commencing and cash payout scheduled for early July.
Victor Sage
Victor Sage
25 June 2026
Firebird Metals has placed all critical equipment orders for its Perth-based Australian Demonstration Plant, triggering the first ARENA grant payment and setting the stage for a pivotal 90-day fabrication phase. The project remains on track for early Q4 2026 equipment delivery, with imminent lithium manganese rich cathode results expected from its China pilot plant.
Maxwell Dee
Maxwell Dee
16 June 2026
Biome Australia has inked a binding deal with Specialty Probiotics Australia to shift its Activated Probiotics manufacturing onshore, aiming to boost gross margins above 65% and streamline working capital within 18 months.
Ada Torres
Ada Torres
3 June 2026
Tourism Holdings Limited (THL) has received a revised acquisition proposal from a BGH-led consortium offering NZ$3.10 per share. Meanwhile, THL has downgraded its FY26 profit guidance and raised its net debt forecast amid ongoing global travel uncertainties.
Victor Sage
Victor Sage
29 May 2026
AdAlta has engaged specialist advisors to streamline US FDA regulatory processes for its CAR-T therapy BZDS1901, which has shown rare complete tumour clearance in advanced mesothelioma patients.
Ada Torres
Ada Torres
25 May 2026
SDI Limited's acquisition by Beijing Guoci's subsidiary advances with ASIC registration of the scheme booklet and court approval to convene a shareholder meeting. The all-cash offer at a 53–58% premium awaits shareholder and final court approval.
Ada Torres
Ada Torres
18 May 2026
MyEco Group is rolling out a new 95% post-consumer recycled bin liner range, fully certified under the Global Recycled Standard, exclusively at Woolworths stores nationwide from late May 2026. This move doubles its Woolworths product lineup and aligns with national sustainability targets.
Victor Sage
Victor Sage
11 May 2026
AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.
Ada Torres
Ada Torres
4 May 2026
Firebird Metals has locked in a purpose-built industrial facility in Osborne Park, Perth, to house its pioneering Australian Demonstration Plant, the only fully integrated manganese concentrate-to-cathode active material facility outside China.
Maxwell Dee
Maxwell Dee
30 Apr 2026

Browse the archive

Full archive